Publication | Closed Access

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome

ObesityInsulin ResistanceMetabolic SyndromeMetabolic DisorderMedicineDiabetesGynecologyMetabolic ComplicationPolycystic Ovary SyndromeLean PatientsEndocrinologyPharmacologyOvarian HormoneHealth Sciences